Heather Denroche, PhD

Director, Preclinical Development
Integrated Nanotherapeutics, Canada

Poster(s):

• Th132 - A Tolerogenic Lipid Nanoparticle Delivery System for Antigen-specific Immune Tolerance
  Thursday, June 20, 2024

  7:30 AM – 7:45 PM PT